Halozyme Therapeutics is a biotech and pharmaceutical company. It is a public company developing and researching healthcare products for diabetics, cancer, dermatology, and drug delivery technology through corporate partnerships. The company was founded in 1998. The headquarter is located in San Deigo, California, United States. The CEO of Halozyme is Helen I. Torley. The subsidiary of it is Halozyme, Inc. Halozyme Therapeutics applies its ENHANCE biotechnology platform to proprietary programs and to a partnership with pharmaceutical and healthcare companies to established and emerging treatments based on recombinant human hyaluronidase and additional enzymes. The ENHANCE technology that they used can reduce hours-long treatments to a matter of minutes. This company consists of about 200 employees working as a team. Halozyme is an organization that, individuals can seek after their career goals and objectives in a supportive, strong team environment.
What departments Halozyme employees work at?
You comment as